Evolution-informed prognostic modelling in myelodysplastic syndromes
ProgEvo and IPSS-M-Evo connect MDS evolutionary routes with leukemia-free and overall survival.
ProgEvoIPSS-M-EvoMDS
Selected peer-reviewed and under-review work behind EvoClin frameworks, clinical evidence layers and cancer evolution modelling.
ProgEvo and IPSS-M-Evo connect MDS evolutionary routes with leukemia-free and overall survival.
Evolution-informed prognostic and metastatic biomarkers for CRC dual risk modelling.
Probabilistic approaches to infer temporal order, co-occurrence and clonal dependencies.
Research programs linking molecular evolution, risk stratification and outcome modelling.
EvoClin combines published evidence with large patient cohorts to build interpretable clinical AI.